Following its announcement to return to Xiamen in 2026, CACLP has received overwhelming enthusiasm from exhibitors worldwide. As of October 2025, more than 1,000 companies have confirmed their participation for next year’s event, reaffirming CACLP’s role as the world‘s largest IVD event and an important annual gathering of the global diagnostic community. 

I. Integrated Product Scopes

CACLP 2026 will showcase a comprehensive range of products and technologies across the entire IVD industry chain:

- Instruments and Reagents for Clinical Laboratory: hematology, biochemistry, immunology, microbiology, molecular diagnostics, and POCT.

- Instruments and Reagents for Pathology: cytopathology, histopathology, immunohistochemistry, and molecular pathology.

- Instruments and Reagents for Transfusion Medicine.

- Instruments and Reagents for Scientific Research.

- Specialized Instruments and Reagents & Supply Chain Solutions: upstream raw materials, components, consumables, and laboratory equipment.

- AI-Powered Smart Healthcare Products, highlighting the integration of digital, intelligent and data-driven innovations into diagnostics.

II. Exhibitor Highlights

Over 1,000 Chinese and international companies, from the top-tier to emerging innovators, will showcase their latest technologies, products, and solutions at CACLP 2026. Global IVD leaders such as Roche, Merck, Thermo Fisher Scientific and Chinese exhibitor Wantai BioPharm, bringing 8 subsidiaries, are among the confirmed participants. Many other renowned multinational and domestic companies will join to unveil their breakthroughs.

III. China Expands Visa-Free Entry

In a timely development for global exhibitors and visitors, China has just announced an expansion of its 240-hour visa-free transit program. The extension of its visa-exemption arrangements for over 40 countries will operate until 31 December 2026.

Travelers from 55 eligible countries can now stay in China for up to 240 hours without a visa before traveling to a third destination. In addition, the unilateral visa-free entry for countries has been extended through 2026, with Sweden newly added to the scheme.

These measures, part of China’s ongoing efforts to facilitate international exchange and cooperation, will make participation in CACLP 2026 even more convenient and accessible.

IV. Concurrent Activities

In 2026, CACLP will once again bring together its full ecosystem of academic and industry events, reinforcing its role as the heart of dialogue and discovery for global diagnostics. 

The following concurrent activities will be held alongside the exhibition:

- The 13th China IVD Industry Development Conference (CIIDC) and series forums

- The 11th China Experimental Medicine Conference (CEMC) and series forums

- The 2nd China AI and Digital Twin Medicine Conference & The 2nd AI and Digital Twin Technology Academic Salon

- The 9th IVD Youth Entrepreneur Forum (ELMY) 

- The 8th China IVD Distribution Enterprise Forum (CIDEF)

- The 6th China IVD Key Raw Materials & Parts Forum (CKRMPF)

- The 2nd National Primary Healthcare Laboratory Forum

- The 2nd China IVD Companies Globalization Forum

- and over 100 business meetings

These sessions will gather 300 academic and industry experts from China and abroad across all sectors of the IVD community. CACLP 2026 will feature dedicated themed zones focusing on AI, global business matchmaking, primary healthcare, and new product Lauches. These areas will be fully integrated into the exhibition halls to maximize efficiency, connectivity, and engagement for all participants.

Now in its 23rd edition, CACLP is evolving from a national platform to a truly global hub for IVD collaboration. The strong early participation of global exhibitors reflects both confidence in CACLP and the collective determination of the industry to advance healthcare innovation and global cooperation.

For companies interested in joining the exhibition or participating in the concurrent events, please leave your message here: en.caclp.com/exhibit-reserve.html

About CACLP 

With over 30 years of industry expertise, China International In Vitro Diagnostic Expo by CACLP, is well established as one of the largest exhibitions in the global in vitro diagnostic industry. Each year, it brings together more than 45,000 professionals—including entrepreneurs, scholars, users, and thought leaders from around the world—to exchange insights, foster partnerships, and collectively shape the future of IVD.

The event covers the entire diagnostics value chain from upstream to downstream, offering a comprehensive showcase of products, technologies, and services. Alongside a great number of high-level academic and educational programs held concurrently onsite, and year-round promotional solutions, CACLP continues to serve as a vital platform for global IVD players.

About GL events

Founded in Lyon in 1978, GL events is world-class leading provider of integrated solutions and services for events operating. GL events’ business covers more than 20 countries across five continents, with over 90 branches and more than 6,000 employees. GL events is listed on the Euronext Paris Segment B in 1998.

Through the unique business model – a complementary mix of products and services addressing the needs of all events and customer expectations.

· LIVE: provide comprehensive solutions from design to deliver events, 6,000 events served annually.

· VENUES: provide venues layout and operation, venues management, technical support, and more customized services, more than 60 venues under management.

· EXHIBITIONS: plan and organize tradeshows to bring together B2B & B2C communities, with 480 proprietary exhibitions.